International audienceThe unique photophysical properties of Ru(II) polypyridyl complexes make them very attractive candidates as photosensitisers in Photodynamic Therapy (PDT). However, to date, there are not many studies exploring in detail the mechanism(s) of action of such compounds in living systems upon light irradiation. This feature article provides an overview of the most in-depth biological studies on such compounds
The use of photodynamic therapy (PDT) against cancer has received increasing attention over recent y...
Photodynamic therapy (PDT) exploits light-activated compounds for therapeutic use. It relies on a ph...
ABSTRACT: Compounds capable of light-triggered cytotox-icity are appealing potential therapeutics, b...
The unique photophysical properties of Ru(ii) polypyridyl complexes make them very attractive candid...
Ruthenium polypyridyl complexes show great promise as new photodynamic therapy (PDT) agents. However...
Nowadays chemotherapy is the most common therapy used to treat cancer. Currently employed drugs are ...
Application of chemotherapeutic agents in current cancer treatment has been limited by adverse effec...
The utilization of photodynamic therapy (PDT) for the treatment of various types of cancer has gaine...
In medicine, light is used in a medical treatment called photodynamic therapy (PDT) to treat some ty...
Ruthenium(II) polypyridyl complexes have been shown to be promising compounds for the design of nove...
Photodynamic therapy (PDT) is a developing cancer treatment involving the use of a photoactive drug ...
Ruthenium complexes capable of light‐triggered cytotoxicity are appealing potential prodrugs for pho...
Lack of selectivity is one of the main issues with currently used chemotherapies, causing damage not...
International audienceComplementary to classical treatment methods used against cancer, photodynamic...
Current chemotherapeutics exhibit debilitating side effects as a result of their toxicity to healthy...
The use of photodynamic therapy (PDT) against cancer has received increasing attention over recent y...
Photodynamic therapy (PDT) exploits light-activated compounds for therapeutic use. It relies on a ph...
ABSTRACT: Compounds capable of light-triggered cytotox-icity are appealing potential therapeutics, b...
The unique photophysical properties of Ru(ii) polypyridyl complexes make them very attractive candid...
Ruthenium polypyridyl complexes show great promise as new photodynamic therapy (PDT) agents. However...
Nowadays chemotherapy is the most common therapy used to treat cancer. Currently employed drugs are ...
Application of chemotherapeutic agents in current cancer treatment has been limited by adverse effec...
The utilization of photodynamic therapy (PDT) for the treatment of various types of cancer has gaine...
In medicine, light is used in a medical treatment called photodynamic therapy (PDT) to treat some ty...
Ruthenium(II) polypyridyl complexes have been shown to be promising compounds for the design of nove...
Photodynamic therapy (PDT) is a developing cancer treatment involving the use of a photoactive drug ...
Ruthenium complexes capable of light‐triggered cytotoxicity are appealing potential prodrugs for pho...
Lack of selectivity is one of the main issues with currently used chemotherapies, causing damage not...
International audienceComplementary to classical treatment methods used against cancer, photodynamic...
Current chemotherapeutics exhibit debilitating side effects as a result of their toxicity to healthy...
The use of photodynamic therapy (PDT) against cancer has received increasing attention over recent y...
Photodynamic therapy (PDT) exploits light-activated compounds for therapeutic use. It relies on a ph...
ABSTRACT: Compounds capable of light-triggered cytotox-icity are appealing potential therapeutics, b...